Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
J. Peter Fasse
J. Peter Fasse is a principal in the Boston, MA, office of Fish & Richardson PC.
More GEN Content From This Contributor
- Columns: Patent Eligibility of Biological Methods and Compositions
- GEN Exclusives: The USPTO's Current View on Patent Eligibility